Performance Study of a Non-invasive Glucose Monitoring Device Prototype
Launched by RSP SYSTEMS A/S · May 8, 2018
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
Protocol consists of two parts:
Part A) Subjects will collect spectral Raman data on device every 15 minutes for 10 hours a day for five days. The five days will be distributed within a timeframe of ten days. A Flash Glucose Monitor will be used as a comparator. In addition to this, four daily capillary Blood Glucose readings will be collected.
Part B) Subjects will perform four daily measuring sessions in which optical Raman readings are paired with capillary Blood Glucose comparator. Measuring sessions are performed in subjects' own home while maintaining usual diabetes management routi...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male and female subjects 18 years of age or older
- • Diabetic patients (all types), insulin requiring
- • Skin phototype 1-4
- Exclusion Criteria:
- • For female participants: Pregnancy or subject is attempting to conceive or not willing and able to practice birth control during the study duration
- • For female participants: Breastfeeding
- • Subjects not able to understand and read Danish
- • In Investigator's opinion, subject is not able to follow instructions as specified in the protocol
- • Rejection by optical screenings
- • Participants not able to hold hand/arm steadily (including tremors and Parkinson's Disease)
- • Diagnosed with reduced circulation
- • Extensive skin changes, tattoos or diseases on probe application site
- • Known allergy to medical grade alcohol
- • Known allergy to adhesives, applicable to subjects in RSP-13-01
- • Systemic or topical administration of glucocorticoids for the past 7 days
- • Subjects undergoing dialysis treatment
- • Medical history or any condition that may, in the opinion of the Investigator, compromise the subject's ability to participate
- • Concomitant medical condition which could present a risk to the safety or welfare of the subject or study staff.
- • Participants currently enrolled in another study
About Rsp Systems A/S
RSP Systems A/S is a leading clinical trial sponsor dedicated to advancing healthcare through innovative research and development. Specializing in the design and management of clinical trials, RSP Systems leverages cutting-edge technology and a robust infrastructure to facilitate efficient study execution. With a commitment to regulatory compliance and patient safety, the organization collaborates with healthcare professionals, research institutions, and industry partners to deliver high-quality data and insights that drive medical advancements. RSP Systems A/S is focused on enhancing therapeutic outcomes across various medical fields, ensuring that new treatments are developed responsibly and effectively.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Odense, , Denmark
Patients applied
Trial Officials
Jan Erik Henriksen, MD, PhD
Principal Investigator
Steno Diabetes Center Odense, Denmark
Vibe Vestergaard, Nurse
Principal Investigator
Steno Diabetes Center Odense, Denmark
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials